Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Paul Schoenhagen, MD, is a Physician in the Department of Diagnostic Radiology and in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine. He is board-certified in internal medicine. His clinical interest is focused on cardiovascular imaging with computed tomography and magnetic resonance imaging. He is also involved in work related to the prevention of cardiovascular disease. Dr. Schoenhagen has a special interest in imaging of coronary atherosclerosis and imaging of the aorta and aortic root.
A native of Koblenz, Germany, Dr. Schoenhagen graduated with a degree in mineralogy from the Ruhr-Universitaet, Bochum, Germany. He received his medical degree from the Karls-Universitaet, Tuebingen, and doctoral degree from the the Philips-Universitaet, Marburg, also in Germany. He received his initial clinical training in internal medicine and radiology in Stuttgart, Germany. This was followed by a residency in internal medicine at Cleveland Clinic, and subsequent fellowships in cardiology and in cardiovascular tomography, also at Cleveland Clinic. Dr. Schoenhagen was appointed to Cleveland Clinic in 2003.
Dr. Schoenhagen has been honored for his clinical research, which has focused on the implications of plaque vulnerability, intravascular ultrasound research and the application of computed tomography and magnetic resonance imaging for atherosclerosis research.
He has published numerous original and review articles in leading peer-reviewed journals such as the Journal of the American Medical Association, Circulation, the Journal of the American College of Cardiology, the European Heart Journal, and the Journal of Heart and Lung Transplantation. Dr. Schoenhagen is first author of a textbook of Coronary Intravascular Ultrasound Imaging, and a textbook of Cardiovascular Computed Tomography. He has contributed to several chapters in other medical textbooks related to his specialty interests. He has been invited to present his clinical experience and research at medical symposia and conferences in Japan, Europe, and nationally.
Dr. Schoenhagen is a Fellow of the Council on Atherosclerosis, Thrombosis and Vascular Biology of the American Heart Association. He is a member of the American College of Physicians, the European Society of Cardiology and the Radiologic Society of North America. He is an affiliate member of the American College of Cardiology.
cardiovascular CT and MRI, Cardiovascular Imaging, Coronary Artery Disease, imaging of the aorta and aortic root, Intravascular Ultrasound
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 8/6/2015, Dr. Schoenhagen has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.